Trials / Sponsors / XyloCor Therapeutics, Inc.
XyloCor Therapeutics, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CA Coronary Artery Disease (CAD) | Phase 2 | 2025-08-27 |
| Recruiting | Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. Refractory Angina, Coronary Artery Disease | Phase 2 | 2025-06-24 |
| Completed | Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) Coronary Artery Disease, Ischemia, Angina Refractory | Phase 1 / Phase 2 | 2020-01-24 |